Arrowhead Pharmaceuticals Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
ABBV | AbbVie | Outperform |
9
|
$163.79 | $178.42 | 12.95% | 11 | $284.74B |
AMGN | Amgen | Outperform |
4
|
$311.29 | $303.65 | 2.64% | 8 | $149.32B |
GILD | Gilead Sciences Inc | Outperform |
11
|
$64.78 | $87.82 | 23.49% | 14 | $81.46B |
ALXN | Alexion Pharmaceuticals | - |
0
|
$182.50 | $177.38 | -100.00% | 0 | $40.34B |
BIIB | Biogen | Outperform |
10
|
$217.51 | $299.62 | 32.64% | 13 | $31.09B |
BMRN | BioMarin Pharmaceutical | Outperform |
10
|
$82.44 | $111.56 | 33.43% | 5 | $15.91B |
INCY | Incyte | Outperform |
9
|
$53.76 | $77.05 | 46.02% | 8 | $11.89B |
VKTX | Viking Therapeutics | Buy |
5
|
$76.97 | $34.00 | 49.41% | 6 | $8.78B |
BPMC | Blueprint Medicines | Outperform |
6
|
$107.19 | $85.71 | 2.62% | 5 | $6.72B |
ARNA | Arena Pharmaceuticals | - |
6
|
$99.99 | $100.00 | -100.00% | 0 | $6.17B |
CCXI | ChemoCentryx | - |
8
|
$51.99 | $52.00 | -100.00% | 0 | $3.74B |
CBAY | CymaBay Therapeutics | - |
8
|
$32.44 | $27.73 | -100.00% | 5 | $3.72B |
IOVA | Iovance Biotherapeutics | Buy |
4
|
$13.63 | $20.42 | 87.09% | 4 | $3.30B |
DRNA | Dicerna Pharmaceuticals | - |
7
|
$38.01 | $35.06 | -100.00% | 0 | $2.99B |
FOLD | Amicus Therapeutics | Outperform |
7
|
$10.40 | $17.90 | 92.31% | 1 | $2.96B |
ACAD | ACADIA Pharmaceuticals | Outperform |
6
|
$17.05 | $33.78 | 75.95% | 6 | $2.76B |
CLDX | Celldex Therapeutics | Buy |
11
|
$42.56 | $63.29 | 80.92% | 1 | $2.81B |
VCEL | Vericel | Buy |
8
|
$47.83 | $42.58 | 14.99% | 0 | $2.22B |
AGIO | Agios Pharmaceuticals | Outperform |
9
|
$34.54 | $40.00 | 28.84% | 4 | $1.96B |
ARDX | Ardelyx | Buy |
11
|
$8.72 | $9.94 | 54.82% | 5 | $2.04B |
ADMA | ADMA Biologics | Buy |
9
|
$6.81 | $6.00 | 17.47% | 0 | $1.51B |
DVAX | Dynavax Technologies | Outperform |
11
|
$11.74 | $25.00 | 108.69% | 1 | $1.49B |
XNCR | Xencor | Outperform |
6
|
$24.11 | $37.91 | 41.02% | 4 | $1.29B |
MNKD | MannKind | Buy |
10
|
$4.39 | $6.92 | 53.76% | 1 | $1.11B |
CATX | Perspective Therapeutics | Buy |
9
|
$1.81 | $1.20 | -17.13% | 0 | $986.02M |
BCRX | BioCryst Pharmaceuticals | Outperform |
7
|
$4.45 | $14.09 | 135.96% | 2 | $918.17M |
SAGE | Sage Therapeutics | Hold |
6
|
$13.94 | $25.28 | 36.30% | 2 | $838.94M |
BLFS | BioLife Solutions | Buy |
9
|
$18.03 | $22.57 | 19.25% | 1 | $794.56M |
OCUL | Ocular Therapeutix | Outperform |
6
|
$6.17 | $12.25 | 143.11% | 3 | $733.40M |
RDUS | Radius Health | - |
4
|
$10.08 | $10.00 | -100.00% | 0 | $485.05M |
ABUS | Arbutus Biopharma | Outperform |
9
|
$2.71 | $6.34 | 100.37% | 0 | $482.87M |
FATE | Fate Therapeutics | Outperform |
7
|
$4.06 | $6.23 | 72.41% | 14 | $462.10M |
TVTX | Travere Therapeutics | Outperform |
8
|
$6.26 | $14.07 | 131.63% | 5 | $476.44M |
KIN | Kindred Biosciences | - |
7
|
$9.25 | $9.25 | 15.57% | 2 | $420.53M |
CRBP | Corbus Pharmaceuticals Holding... | Buy |
6
|
$38.77 | $20.00 | 41.86% | 3 | $389.19M |
ANIK | Anika Therapeutics | Outperform |
10
|
$27.59 | $27.33 | 15.98% | 2 | $404.52M |
RVNC | Revance Therapeutics | Outperform |
6
|
$3.95 | $26.92 | 254.43% | 5 | $376.22M |
HRTX | Heron Therapeutics | Buy |
7
|
$2.61 | $5.63 | 149.04% | 0 | $349.48M |
CERS | Cerus | Outperform |
6
|
$1.62 | $4.13 | 208.64% | 1 | $299.52M |
PFNX | Pfenex | - |
2
|
$0.00 | $13.00 | 0.00% | 0 | $301.67M |
CNCE | Concert Pharmaceuticals | - |
6
|
$8.37 | $17.00 | -100.00% | 0 | $293.84M |
ENTA | Enanta Pharmaceuticals | Outperform |
10
|
$15.17 | $23.88 | 31.84% | 2 | $290.68M |
CRMD | CorMedix | Outperform |
10
|
$5.84 | $14.25 | 105.48% | 0 | $288.93M |
VNDA | Vanda Pharmaceuticals | - |
0
|
$4.88 | $4.25 | 6.76% | 0 | $277.02M |
AKBA | Akebia Therapeutics | Outperform |
8
|
$1.37 | $4.33 | 264.96% | 2 | $263.81M |
EPZM | Epizyme | - |
6
|
$1.47 | $6.00 | -100.00% | 0 | $255.91M |
CDXS | Codexis | Buy |
6
|
$3.92 | $5.83 | 27.55% | 3 | $235.66M |
STML | Stemline Therapeutics | - |
7
|
$169.15 | $12.50 | -100.00% | 0 | $229.28M |
CHRS | Coherus BioSciences | Outperform |
6
|
$2.27 | $10.86 | 252.42% | 3 | $222.46M |
ADRO | Aduro Biotech | - |
6
|
$2.59k | $18.75 | -100.00% | 0 | $221.28M |
ALDX | Aldeyra Therapeutics | Buy |
7
|
$4.16 | $9.40 | 140.38% | 0 | $247.16M |
CLVS.Q | Clovis Oncology | - |
6
|
$0.02 | $1.50 | -100.00% | 0 | $208.62M |
ABEO | Abeona Therapeutics | Buy |
8
|
$4.60 | $21.25 | 269.57% | 2 | $207.08M |
OMER | Omeros | Hold |
11
|
$3.73 | $13.00 | -100.00% | 2 | $182.52M |
BLUE | bluebird bio | Hold |
6
|
$0.90 | $7.20 | 344.44% | 2 | $170.98M |
XOMA | XOMA | Outperform |
2
|
$23.13 | $74.00 | 219.93% | 0 | $169.90M |
LJPC | La Jolla Pharmaceutical | - |
11
|
$6.22 | $6.23 | -100.00% | 0 | $154.54M |
RGLS | Regulus Therapeutics | Outperform |
10
|
$2.65 | $7.67 | 183.02% | 3 | $139.44M |
ORMP | Oramed Pharmaceuticals | Hold |
8
|
$2.35 | $4.30 | 80.85% | 0 | $126.66M |
GLYC | GlycoMimetics | Buy |
10
|
$1.83 | $7.67 | 337.16% | 1 | $117.94M |
DMAC | DiaMedica Therapeutics | Buy |
2
|
$3.00 | $8.33 | 133.33% | 0 | $116.14M |
CLRB | Cellectar Biosciences | Buy |
6
|
$3.42 | $12.00 | 265.50% | 1 | $114.80M |
LIFE | aTyr Pharma | Outperform |
10
|
$1.61 | $26.00 | 1142.24% | 2 | $93.11M |
CMRX | Chimerix | Buy |
10
|
$0.95 | $7.33 | 636.84% | 4 | $85.15M |
MNOV | MediciNova | Buy |
4
|
$1.50 | $16.50 | 1000.00% | 0 | $80.44M |
ATRA | Atara Biotherapeutics | Hold |
5
|
$0.67 | $4.83 | 146.27% | 3 | $79.30M |
MRNS | Marinus Pharmaceuticals | Outperform |
6
|
$1.51 | $20.30 | 297.35% | 1 | $77.44M |
ASMB | Assembly Biosciences | Outperform |
11
|
$13.15 | $3.00 | 173.76% | 2 | $73.52M |
CDTX | Cidara Therapeutics | Buy |
6
|
$12.51 | $4.67 | 99.84% | 1 | $61.71M |
PTN | Palatin Technologies | Buy |
4
|
$2.11 | $43.00 | 184.36% | 0 | $56.60M |
SCYX | SCYNEXIS | Buy |
6
|
$1.77 | $7.13 | 281.36% | 2 | $54.37M |
CARA | Cara Therapeutics | Outperform |
6
|
$0.78 | $12.14 | 541.03% | 0 | $49.58M |
BCLI | Brainstorm Cell Therapeutics | Hold |
4
|
$0.38 | $0.50 | 557.89% | 0 | $36.36M |
NLTX | Neoleukin Therapeutics | - |
6
|
$13.96 | $21.57 | -100.00% | 0 | $31.01M |
V9Z | Aceragen | - |
7
|
0.47€ | 1.00€ | -100.00% | 0 | 25.39€M |
LSTA | Lisata Therapeutics | Buy |
8
|
$2.85 | $16.00 | 408.77% | 2 | $23.85M |
AYTU | Aytu BioPharma | Outperform |
9
|
$3.01 | $5.00 | 165.78% | 0 | $17.54M |
NERV | Minerva Neurosciences | Hold |
4
|
$2.37 | $11.00 | 195.36% | 1 | $17.34M |
ACOR | Acorda Therapeutics | - |
5
|
$0.43 | $200.00 | -100.00% | 1 | $15.89M |
PIRS | Pieris Pharmaceuticals | - |
9
|
$11.08 | $7.00 | -100.00% | 0 | $14.35M |
TRVN | Trevena | Outperform |
2
|
$0.61 | $5.18 | 555.74% | 0 | $9.38M |
HEPA | Hepion Pharmaceuticals | Outperform |
7
|
$1.46 | $30.00 | 1954.79% | 0 | $7.50M |
PSTV | Plus Therapeutics | Outperform |
11
|
$1.80 | $11.00 | 733.33% | 2 | $7.35M |
TENX | Tenax Therapeutics | Outperform |
4
|
$3.84 | $5.50 | 746.35% | 1 | $7.11M |
XBIO | Xenetic Biosciences | Hold |
8
|
$3.85 | $4.00 | 4.68% | 0 | $5.98M |
NHWK | NightHawk Biosciences | Hold |
8
|
$0.19 | $10.00 | 5163.16% | 0 | $5.66M |
TCON | TRACON Pharmaceuticals | Outperform |
9
|
$1.86 | $4.00 | 1916.13% | 0 | $4.46M |
BPTH | Bio-Path Holdings | Outperform |
5
|
$2.61 | $12.00 | 1432.57% | 1 | $3.96M |
CYCC | Cyclacel Pharmaceuticals | Outperform |
5
|
$2.00 | $240.00 | 8050.00% | 0 | $3.49M |
ARAV | Aravive | - |
10
|
$0.04 | $0.25 | -50.00% | 0 | $2.95M |
ADXS | Advaxis | - |
8
|
$0.80 | $2.25 | -100.00% | 0 | $2.45M |
ATHX | Athersys | - |
6
|
$0.00 | $5.50 | 0.00% | 1 | $0.87M |
BLCM | Bellicum Pharmaceuticals | - |
6
|
$0.06 | $5.00 | -100.00% | 0 | $0.77M |
BLPH | Bellerophon Therapeutics | - |
7
|
$0.06 | $2.00 | -50.00% | 0 | $0.40M |
CFRX.Q | ContraFect |
5
|
$0.02 | $7.00 | 34900.00% | 0 | $0.32M | |
CALA | Calithera Biosciences | - |
6
|
$0.02 | $7.71 | -100.00% | 1 | $0.10M |
GNCA.Q | Genocea Biosciences | - |
9
|
$0.00 | $6.00 | 0.00% | 0 | $0.00M |
XLRN | Acceleron Pharma | - |
0
|
$179.68 | $177.75 | -100.00% | 0 | $0.00M |
AGTC | Beacon Therapeutics (USA) | - |
11
|
$0.39 | $0.37 | -100.00% | 1 | $0.00M |
ONCS.Q | OncoSec Medical | - |
7
|
$0.00 | $110.00 | 0.00% | 0 | $0.00M |